Lumeran, Jerald Kurt D.
HRN: 21-74-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/15/2024
04/22/2024
IV
150mg
Q6
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes